Epidermal growth factor receptor (EGFR)-activating mutations (mut) and response to gefitinib in lung adenocarcinoma.

被引：0
|
作者：
Cortes-Funes, H
Almanza, C
Valero, P
Giron, CG
Velasco, A
Colomer, R
Camps, C
Diz, P
Taron, M
Rosell, R
机构：
[1] Univ Madrid, Hosp Octobre 12, Madrid 3, Spain
[2] Clin Povisa, Vigo, Pontevedra, Spain
[3] Clin Sagrado Corazon, Seville, Spain
[4] Hosp Gen Yague, Burgos, Spain
[5] Univ Madrid, Hosp La Princesa, Madrid 3, Spain
[6] Hosp Josep Trueta, Inst Catala Oncol, Girona, Spain
[7] Hosp Gen Valencia, Valencia, Spain
[8] Hosp Leon, Leon, Spain
[9] Inst Catala Oncol, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：639S / 639S
页数：1
相关论文
共 50 条
  • [1] Epidermal growth factor receptor (EGFR)-activating mutations (mut) and response to gefitinib in lung adenocarcinomas
    Moran, T
    de Castellanos, D
    Gomez, C
    Valero, P
    Alberola, V
    Gonzalez-Larriba, J
    Massuti, B
    Maestu, I
    Izquierdo, A
    Queralt, C
    LUNG CANCER, 2005, 49 : S110 - S110
  • [2] EFFICACY OF GEFITINIB AND ERLOTINIB IN INDONESIAN PATIENTS WITH LUNG ADENOCARCINOMA WITH ACTIVATING EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS
    Asdar, Muhammad Ali
    Syahruddin, Elisna
    Zaini, Jamal
    RESPIROLOGY, 2019, 24 : 55 - 56
  • [3] Good Response to Gefitinib in Lung Adenocarcinoma of Complex Epidermal Growth Factor Receptor (EGFR) Mutations with the Classical Mutation Pattern
    Wu, Shang-Gin
    Chang, Yih-Leong
    Hsu, Ya-Chieh
    Wu, Jenn-Yu
    Yang, Chih-Hsin
    Yu, Chong-Jen
    Tsai, Meng-Feng
    Shih, Jin-Yuan
    Yang, Pan-Chyr
    ONCOLOGIST, 2008, 13 (12): : 1276 - 1284
  • [4] Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations
    Yano, Seiji
    Wang, Wei
    Li, Qi
    Matsumoto, Kunio
    Sakurama, Haruko
    Nakamura, Takahiro
    Ogino, Hirokazu
    Kakiuchi, Soji
    Hanibuchi, Masaki
    Nishioka, Yasuhiko
    Uehara, Hisanori
    Mitsudomi, Tetsuya
    Yatabe, Yasushi
    Nakamura, Toshikazu
    Sone, Saburo
    CANCER RESEARCH, 2008, 68 (22) : 9479 - 9487
  • [5] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS IN ADVANCED LUNG ADENOCARCINOMA
    Chai, Chee Shee
    Liam, Chong-Kin
    RESPIROLOGY, 2015, 20 : 89 - 89
  • [6] Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations
    Kim, Min Hwan
    Kim, Hye Ryun
    Cho, Byoung Chul
    Bae, Mi Kyung
    Kim, Eun Young
    Lee, Chang Young
    Lee, Jae Seok
    Kang, Dae Ryong
    Kim, Joo Hang
    LUNG CANCER, 2014, 84 (02) : 196 - 202
  • [7] Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
    Wu, Shang-Gin
    Yang, Chih-Hsin
    Yu, Chong-Jen
    Lee, Jih-Hsiang
    Hsu, Ya-Chieh
    Chang, Yih-Leong
    Shih, Jin-Yuan
    Yang, Pan-Chyr
    LUNG CANCER, 2011, 72 (03) : 333 - 339
  • [8] Favorable Response to Gefitinib Treatment of Lung Adenocarcinoma With Coexisting Germline and Somatic Epidermal Growth Factor Receptor Mutations
    Chung, Kuei-Pin
    Shih, Jin-Yuan
    Yu, Chong-Jen
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (34) : E701 - E703
  • [9] Rare double mutations in epidermal growth factor receptor (EGFR) mutant adenocarcinoma of lung
    Jayaprakash, K. Thippu
    Yang, H.
    Aslam, S.
    Jeffs, Y.
    Jessop, S.
    Bulusu, V. R.
    LUNG CANCER, 2019, 127 : S92 - S93
  • [10] Epidermal growth factor receptor mutations in lung adenocarcinoma
    Siegelin, Markus D.
    Borczuk, Alain C.
    LABORATORY INVESTIGATION, 2014, 94 (02) : 129 - 137
12345